NO332112B1 - Isolert, syntetisk eller rekombinant nukleinsyremolekyl og polypeptid, ekspresjonsvektor, fremgangsmate for a produsere nystatin eller et nystatinderivat, anvendelse av et nukleinsyremolekyl, fremgangsmate for fremstilling av et modifisert PKS-system og nystatin, modifisert PKS-system, vertscelle, nystatinderivat samt antibiotikum. - Google Patents
Isolert, syntetisk eller rekombinant nukleinsyremolekyl og polypeptid, ekspresjonsvektor, fremgangsmate for a produsere nystatin eller et nystatinderivat, anvendelse av et nukleinsyremolekyl, fremgangsmate for fremstilling av et modifisert PKS-system og nystatin, modifisert PKS-system, vertscelle, nystatinderivat samt antibiotikum. Download PDFInfo
- Publication number
- NO332112B1 NO332112B1 NO20023741A NO20023741A NO332112B1 NO 332112 B1 NO332112 B1 NO 332112B1 NO 20023741 A NO20023741 A NO 20023741A NO 20023741 A NO20023741 A NO 20023741A NO 332112 B1 NO332112 B1 NO 332112B1
- Authority
- NO
- Norway
- Prior art keywords
- nystatin
- seq
- nucleic acid
- acid molecule
- pks
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0002840A GB0002840D0 (en) | 2000-02-08 | 2000-02-08 | Novel genes and their manipulation and utility |
| GB0008786A GB0008786D0 (en) | 2000-04-10 | 2000-04-10 | Novel genes and their manipulation and utility |
| GB0009387A GB0009387D0 (en) | 2000-04-14 | 2000-04-14 | Novel genes and their manipulation and utility |
| PCT/GB2001/000509 WO2001059126A2 (en) | 2000-02-08 | 2001-02-08 | Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20023741D0 NO20023741D0 (no) | 2002-08-07 |
| NO20023741L NO20023741L (no) | 2002-10-07 |
| NO332112B1 true NO332112B1 (no) | 2012-06-25 |
Family
ID=27255517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023741A NO332112B1 (no) | 2000-02-08 | 2002-08-07 | Isolert, syntetisk eller rekombinant nukleinsyremolekyl og polypeptid, ekspresjonsvektor, fremgangsmate for a produsere nystatin eller et nystatinderivat, anvendelse av et nukleinsyremolekyl, fremgangsmate for fremstilling av et modifisert PKS-system og nystatin, modifisert PKS-system, vertscelle, nystatinderivat samt antibiotikum. |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7141660B2 (https=) |
| EP (1) | EP1255840A2 (https=) |
| JP (1) | JP4902925B2 (https=) |
| AU (2) | AU784995B2 (https=) |
| CA (1) | CA2399689A1 (https=) |
| NO (1) | NO332112B1 (https=) |
| WO (1) | WO2001059126A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2360011A1 (en) | 1999-01-05 | 2000-07-13 | Trustees Of Boston University | Ordered gene assembly |
| FR2907465A1 (fr) * | 2006-10-18 | 2008-04-25 | Commissariat Energie Atomique | Polynucleotides et polypeptides codes par lesdits polynucleotides impliques dans la voie de biosynthese de la congocidine et ses derives |
| GB0712881D0 (en) * | 2007-07-03 | 2007-08-15 | Biosergen As | Compounds |
| GB0805363D0 (en) | 2008-03-20 | 2008-04-30 | Sinvent As | Novel NRPS-PKS gene cluster and its manipulation and utility |
| EP2546345A1 (en) * | 2008-06-04 | 2013-01-16 | Eisai R&D Management Co., Ltd. | DNA encoding polypeptide involved in biosynthesis of herboxidiene |
| EP3247378B8 (en) | 2015-01-09 | 2023-08-23 | Revolution Medicines, Inc. | Macrocyclic compounds that participate in cooperative binding and medical uses thereof |
| CN109641062A (zh) | 2016-04-12 | 2019-04-16 | 华普卓威生物公司 | 用于产生化合物的组合物和方法 |
| GB2553356A (en) * | 2016-09-05 | 2018-03-07 | Geomec Eng Ltd | Improvements in or relating to geothermal power plants |
| US11479797B2 (en) * | 2016-10-28 | 2022-10-25 | Ginkgo Bioworks, Inc. | Compositions and methods for the production of compounds |
| CN110423790B (zh) * | 2019-08-16 | 2021-04-02 | 上海交通大学 | 一种抗真菌四霉素b定向高产的代谢工程方法 |
| TW202132316A (zh) | 2019-11-04 | 2021-09-01 | 美商銳新醫藥公司 | Ras抑制劑 |
| AU2020377925A1 (en) | 2019-11-04 | 2022-05-05 | Revolution Medicines, Inc. | Ras inhibitors |
| IL322454A (en) | 2019-11-04 | 2025-09-01 | Revolution Medicines Inc | ras inhibitors |
| US11049590B1 (en) | 2020-02-12 | 2021-06-29 | Peptilogics, Inc. | Artificial intelligence engine architecture for generating candidate drugs |
| CA3194067A1 (en) | 2020-09-15 | 2022-03-24 | Revolution Medicines, Inc. | Ras inhibitors |
| US11403316B2 (en) | 2020-11-23 | 2022-08-02 | Peptilogics, Inc. | Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates |
| KR20240017811A (ko) | 2021-05-05 | 2024-02-08 | 레볼루션 메디슨즈, 인크. | 암의 치료를 위한 ras 억제제 |
| US11512345B1 (en) | 2021-05-07 | 2022-11-29 | Peptilogics, Inc. | Methods and apparatuses for generating peptides by synthesizing a portion of a design space to identify peptides having non-canonical amino acids |
| AR127308A1 (es) | 2021-10-08 | 2024-01-10 | Revolution Medicines Inc | Inhibidores ras |
| GB202207185D0 (en) | 2022-05-17 | 2022-06-29 | Sintef Tto As | Novel antibiotic compound |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2654339B1 (fr) | 1989-11-14 | 1994-10-28 | Mayoly Spindler Laboratoires | Nouveaux derives solubles et non toxiques des macrolides polyeniques basiques, leur preparation et leurs applications. |
| US5210226A (en) | 1990-02-02 | 1993-05-11 | Xechem Inc. | Method for separating and purifying polyene macrolide antibiotics |
| DE59106126D1 (de) * | 1990-03-07 | 1995-09-07 | Hoffmann La Roche | Verfahren zur herstellung von derivaten der ascorbinsäure. |
| US5712146A (en) | 1993-09-20 | 1998-01-27 | The Leland Stanford Junior University | Recombinant combinatorial genetic library for the production of novel polyketides |
| CA2188257A1 (en) | 1994-04-22 | 1995-11-02 | Juan Jose R. Coque | Dna encoding cephamycin biosynthesis late enzymes |
| CA2197524A1 (en) | 1996-02-22 | 1997-08-22 | Bradley Stuart Dehoff | Polyketide synthase genes |
| NZ500693A (en) | 1997-04-30 | 2004-01-30 | Kosan Biosciences Inc | Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold |
| US5981721A (en) * | 1997-10-23 | 1999-11-09 | Karykion Corporation | Polyene macrolide schiff bases, their alkyl esters and processes for preparing polyene macrolide alkyl ester salts thereof |
| WO2000077222A1 (en) | 1999-06-14 | 2000-12-21 | Dsm N.V. | Genes encoding enzymes in the biosynthesis of pimaricin and the application thereof |
-
2001
- 2001-02-08 US US10/203,295 patent/US7141660B2/en not_active Expired - Fee Related
- 2001-02-08 WO PCT/GB2001/000509 patent/WO2001059126A2/en not_active Ceased
- 2001-02-08 EP EP01904115A patent/EP1255840A2/en not_active Withdrawn
- 2001-02-08 CA CA002399689A patent/CA2399689A1/en not_active Abandoned
- 2001-02-08 JP JP2001558462A patent/JP4902925B2/ja not_active Expired - Fee Related
- 2001-02-08 AU AU32034/01A patent/AU784995B2/en not_active Ceased
-
2002
- 2002-08-07 NO NO20023741A patent/NO332112B1/no not_active IP Right Cessation
-
2006
- 2006-09-04 AU AU2006206147A patent/AU2006206147B2/en not_active Ceased
- 2006-09-11 US US11/518,287 patent/US7709231B2/en not_active Expired - Fee Related
-
2010
- 2010-03-29 US US12/748,759 patent/US7851183B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006206147A1 (en) | 2006-09-28 |
| NO20023741L (no) | 2002-10-07 |
| AU3203401A (en) | 2001-08-20 |
| WO2001059126A3 (en) | 2002-03-14 |
| US7851183B2 (en) | 2010-12-14 |
| NO20023741D0 (no) | 2002-08-07 |
| WO2001059126A2 (en) | 2001-08-16 |
| JP2003528592A (ja) | 2003-09-30 |
| US7141660B2 (en) | 2006-11-28 |
| AU2006206147B2 (en) | 2008-12-18 |
| US20040115762A1 (en) | 2004-06-17 |
| AU784995B2 (en) | 2006-08-17 |
| US7709231B2 (en) | 2010-05-04 |
| EP1255840A2 (en) | 2002-11-13 |
| US20100216870A1 (en) | 2010-08-26 |
| CA2399689A1 (en) | 2001-08-16 |
| US20080119541A1 (en) | 2008-05-22 |
| JP4902925B2 (ja) | 2012-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7851183B2 (en) | Genes encoding a nystatin polyketide synthase and their manipulation and utility | |
| EP1244800B1 (en) | Rapamycin analogs | |
| CA2347412A1 (en) | Recombinant oleandolide polyketide synthase | |
| US20090176969A1 (en) | Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use | |
| US6627427B1 (en) | Heterologous production of 15-methyl-6-deoxyerthronolide B | |
| JP2003528592A5 (https=) | ||
| EP0910633A2 (en) | Polyketides and their synthesis | |
| HUP0105179A2 (hu) | Poliketidek és szintézisük | |
| JP5037771B2 (ja) | グリコシル化されたハイブリッド産物およびその産生方法と利用 | |
| WO2000001827A2 (en) | Polyketides, their preparation, and materials for use therein | |
| EP1414969B1 (en) | Biosynthetic genes for butenyl-spinosyn insecticide production | |
| CA2463167A1 (en) | Production, detection and use of transformant cells | |
| US6960453B1 (en) | Hybrid polyketide synthases combining heterologous loading and extender modules | |
| EP1183369A1 (en) | Polyketides and their synthesis | |
| AU2008201937B2 (en) | Biosynthetic genes for butenyl-spinosyn insecticide production | |
| US20050266434A1 (en) | Biosynthetic gene cluster for ambruticins | |
| Lum | Reverse engineering industrial bacteria that overproduce antibiotics | |
| AU2002305118A1 (en) | Biosynthetic genes for butenyl-spinosyn insecticide production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |